Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a condition where stomach contents reflux causes troublesome symptoms like heartburn and regurgitation, GERD’s diagnosis often involves endoscopy and reflux monitoring, especially for patients unresponsive to initial treatments. Advanced diagnostic tools such as pH or impedance-pH monitoring and high-resolution esophageal manometry help clinicians confirm GERD and assess for surgical suitability in more severe cases. Evolving treatments include tailored use of proton pump inhibitors (PPIs), novel medical therapies, and endoscopic procedures. Explore the full article for a comprehensive review of diagnostic and management strategies that are helping clinicians better address this pervasive condition.
Trending
- Why Have All the Doctors Gone? Insights Into Early Clinical Departure Among Physicians in the United States: A National Survey (The Permanente Journal )
- Subcutaneous Guselkumab Meets Week 12 Endpoint In Ulcerative Colitis (ReachMD)
- Virtual Colonoscopies Expand Colorectal Cancer Screening Possibilities (HealthCity)
- 10 prior authorization changes physicians should watch (Medical Economics)
- Lawmakers mull Medicare physician pay reform to tamp down consolidation (Healthcare Dive)
- Magnetic neuromodulation reduced fecal incontinence (GI & Hepatology News)
- Layering Weight-Loss Medications With Surgery and Other Tips for Obesity Management (GI & Endoscopy News)
- The $500K Club (Medscape)
